Kairos Pharma Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.37

+0.01 (+3.36%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,078.9% upside

Low Target $5.03

Average Target $8.04

High Target $9.33

Current Price $0.37

Current
$0.37

Target
$8.04

$5.03 $8.04 avg $9.33

Scenario Analysis

Bear Case

$5.03

1,263.1%

Low target

Base Case

$8.04

+2,078.9%

Avg target

Bull Case

$9.33

+2,428.5%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$2.11

-82.5% from high

52-Week Low

$0.37

+-1.0% from low

Target vs 52W High

$8.04

+281.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-38.5%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%